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Abstract By means of circular dichroism and fluorescence 
spectroscopy, viscometry and scanning microcalorimetry we have 
shown that the release of ligands from human a-fetoprotein 
(AFP) results in a considerable rearrangement of the protein 
molecule. Ligand-free form is practically as compact as the 
native molecule and has native-like content of secondary 
structure but no rigid tertiary structure. This means that the 
release of ligands transforms the AFP molecule into a molten 
globule state. Stripping the ligands from AFP is the irreversible 
process, i.e., native protein molecule cannot be reconstituted 
from the ligand-free form of AFP by adding back ligands. A 
possible functional role of such a structural transformation is 
discussed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
a-Fetoprotein (AFP) is a large ( ~ 6 7 kDa) cancero-devel-
opmental glycoprotein the content of which is high ( ~ 10 mg/ 
ml) in embryonal and fetal sera but decreases to trace 
amounts soon after birth. Increase of A F P concentration in 
adults is a sign of the development of some pathological con-
ditions [1-3]. Changes in A F P content during pregnancy is 
also of diagnostic importance as this indicates the develop-
ment of many fetal abnormalities [4-6]. The physiological 
role of A F P is very diverse from binding of various ligands 
[7-12] to regulation of immune response [12-14], 
The molten globule state is an equilibrium state of many 
proteins whose structural properties are intermediate between 
those of native and unfolded protein molecules. This state is 
compact and has a number of important features of the native 
secondary structure and the overall native architecture, but its 
rigid tertiary structure is either absent or strongly reduced (for 
a recent review see Ref. [15] and references therein). It was 
shown that the molten globule, being separated from the na-
tive and unfolded states by 'all-or-none' transitions, represents 
a third thermodynamic state of protein molecules [16-18]. The 
functional role of this intermediate state is discussed [19]. 
In the present paper we investigate the effect of release of 
natural ligands on structural properties and conformational 
stability of A F P . We show that the formation of a ligand-
free form is an irreversible process which transforms the 
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A F P molecule into a compact denatured intermediate with 
pronounced secondary structure, i.e., into the molten globule 
state. A possible functional role of such a structural trans-
formation is suggested. 
2. Materials and methods 
2.1. Materials 
AFP was isolated from human cord serum by the procedure de-
scribed in Ref. [20]. The protein purity was no less than 98% accord-
ing to SDS and native polyacrylamide gel electrophoresis (PAGE) 
with immunoblotting and reversed-phase chromatography. 
Hexane and powdered charcoal (Norit, Serva) were of extra pure 
grade. Buffer compounds, of analytical or extra pure grade, were used 
without additional purification. The pH values were adjusted by ad-
dition of 0.5-1.0 M NaOH or HC1. All solutions were prepared in 
bidistilled water. Measurements were carried out in 100 mM sodium 
phosphate buffer (pH 7.2) containing 0.15 M NaCl (PBS buffer). 
2.2. Experimental procedure 
Hydrophobic ligands were released from the AFP molecules by 
charcoal [21,22] or hexane treatment. To this end, protein solution 
at pH 6.0 was mixed with a portion of charcoal or hexane. In the first 
case, the weight ratio charcoal/protein was equal to 5:1; in the second 
case, the volume ratio 1:1 was used. The mixture was stirred for 12 h 
at room temperature, before being centrifuged. The aqueous fraction 
was collected, filtered and passed through a small gel-filtration column 
(G-75) equilibrated with PBS buffer. Completeness of ligand release 
was controlled by gas chromatography. Chromatographic profiles ob-
tained for AFP after the above procedures contain the only peak 
corresponding to protein molecules. 
Addition of arachidonic acid to lipid-free AFP was carried out as 
follows. An amount of fatty acid (FA) sufficient to provide a 10-fold 
molar excess over the amount of protein to be employed was dissolved 
in ethanol. A small aliquot (10 ul) of this solution was then added to 
1000 ul of solution of ligand-free AFP in distilled water and the 
contents were allowed to react for 2 h at room temperature with 
gentle shaking. Finally the reaction mixture was passed through a 
small gel-filtration column (G-75) equilibrated with PBS buffer. The 
presence of fatty acids in the reconstituted samples of AFP was 
checked by gas and reversed-phase chromatography. The incorpora-
tion of arachidonic acid in AFP was not detected. 
Protein concentrations were measured by absorbance at 280 nm on 
Cary-219 spectrophotometer (Varian, Australia) using the extinction 
coefficient (ejmi 280nm) 0.365. For circular dichroism (CD) and calori-
metric measurements, protein concentration was 0.5-1.0 mg/ml, fluo-
rescence investigations were done using 0.01 mg/ml protein solutions, 
viscometry investigations were carried out at protein concentration 
1.0-7.0 mg/ml. 
CD spectra were obtained on a Jasko-600 spectropolarimeter (Ja-
pan Spectroscopic, Tokyo, Japan) equipped with a temperature-con-
trolled holder. For far- and near-UV measurements 0.148 and 10 mm 
pathlength cells were used, respectively. 
Calorimetric measurements were carried out using DASM-5M pre-
cision scanning microcalorimeter (Bureau of Biological Instrumenta-
tion, Pushchino, Russia) with a cell volume of 1 ml. The rate of 
heating was 1 K/min. The excess pressure was kept equal to 3.6 atm. 
Intrinsic viscosity [r|] was determined as 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 6 0 6 - 6 
V.N. Uversky et al.lFEBS Letters 410 (1997) 280-284 281 
[n] = lim^o nred = limc_0(Tl-'no)/
TloC, 
where T| is the viscosity of the protein solution of concentration c and 
"Ho is the viscosity of the solvent. Reduced viscosity r|red values were 
measured with a Zimm rotation viscosimeter (Bureau of Biological 
Instrumentation, Pushchino, Russia) and were calculated as 
Tired = {t-k)/kC 
where t and to correspond to the time of one turn of the rotor in the 
protein solution of concentration c or in the solvent, respectively. 
3. Results 
3.1. Release ofligands results in denaturation of AFP molecule 
It is well-known that aromatic CD signals are determined 
by the incorporation of aromatic residues into the rigid chiral 
environment, i.e., by the presence of unique tertiary structure 
in a protein molecule. Decrease of elipticity in this region 
reflects the reduction in ordered tertiary structure upon 
change of experimental conditions. Near-UV CD spectra of 
AFP in different conformational states (native, ligand-free and 
completely unfolded by 9.5 M urea) are presented in Fig. 1A. 
Ligand-free form of AFP was obtained either by charcoal or 
hexane treatment (see below). One can see that near-UV CD 
spectrum of native AFP is not very intense, but is consistent 
with the presence of asymmetry in the environment of aro-
matic amino acid residues, i.e., with the presence of rigid 
tertiary structure. At the same time, spectra of the ligand-
free form are much less pronounced and very close to the 
near-UV CD spectrum of completely unfolded AFP. This 
means that release of ligands results in destruction of the 
unique tertiary structure in the protein molecule, i.e., leads 
to its denaturation. 
This suggestion was confirmed by the results of calorimetric 
measurements which are presented in Fig. IB. One can see 
that the temperature course of the excess heat capacity for 
native AFP is the typical calorimetric curve that has a single 
heat absorption peak. The presence of such a peak reflects 
cooperative disruption of rigid tertiary structure of a protein 
molecule [15,23]. This means that, in the presence of natural 
ligands, AFP has a rigid tertiary structure which can be co-
operatively destroyed by heating. From analysis of the calo-
rimetric curve, it is possible to determine calorimetric (AH™1) 
and van 't Hoff (A/^11) enthalpy values. Comparison of these 
two quantities provides information on the mechanism of a 
given temperature-induced transition [23]. In our case, 
AHcal = 4S0 kJ/M, AHvH = 5\0 kJ/M and AHvB/AHc,il = 1.1. 
This means that temperature-induced denaturation of the li-
gand-saturated form of AFP is a two-state process. Interest-
ingly, van 't Hoff enthalpy of AFP melting is considerably 
lower than the typical AIT1* values measured for proteins of 
this molecular weight [24]. Such low A/f11 values obtained for 
AFP cannot be explained by the partial denaturation of this 
protein in the initial samples. Indeed, we have established that 
the ligand-saturated form of AFP possesses high resistance 
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Fig. 1. A: Near-UV CD spectra of human AFP in native (1), li-
gand-free (2,3) and completely unfolded by 9.5 M urea (4) states. 
Defatted forms of the protein were obtained by charcoal (2) or hex-
an (3) treatment. Measurements were done at 23°C. B: Temperature 
dependence of partial molar heat capacity of AFP in the presence 
(1) or absence (2,3) of hydrophobic ligands. Ligand-free forms of 
the protein were obtained by charcoal (2) or hexane (3) extraction. 
All measurements were done in 100 mM sodium phosphate buffer 
(pH 7.2) containing 0.15 M NaCl. The protein concentration was 
1.0 mg/ml throughout the experiments. 
towards proteolytic digestion (data will be published else-
where), whereas it is known that partially denatured protein 
molecules are rather unstable in respect to proteolysis. 
It is necessary to emphasize that temperature-induced de-
naturation of AFP molecules is the irreversible process. We 
have ascertained that such behaviour is due to the irreversible 
release of ligands from AFP and this is also the case for other 
types of denaturing action (increase of urea concentration or 
decrease of pH value, see Ref. [25] for details). 
In the case of ligand-free form of AFP, we did not obtain 
any visible heat absorption (see Fig. IB). Thus, we can con-
Table 1 
Structural properties of human AFP in different conformational states 
Conformational state Melting peak [0]265 [©feo [n] 
(deg cm2 dM"1) (deg cm2 dM"1) (ml/g) 
«s(A) RJRf, 
Native 
Ligand-free 
Unfolded 
5513 
3513 
30 + 3 
15 2001200 
146001200 
700+100 
3.310.5 
5.610.8 
33.7 + 0.8 
32.3 
38.5 
70.0 
1.00 
1.19 
2.17 
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Fig. 2. Far-UV CD spectra of AFP in natural (1), defatted (2,3) 
and completely unfolded (4) forms. Measurements were done in 100 
mM sodium phosphate buffer (pH 7.2) containing 0.15 M NaCl at 
23°C. Protein concentration was 0.5 mg/ml for all the experiments. 
elude that the ligand-free form of AFP has no cooperatively 
melted rigid tertiary structure, i.e., it is denatured. 
3.2. Stripped form of AFP has native-like content of secondary 
structure 
Fig. 2 shows far-UV CD spectra of AFP in the native state 
(100 mM phosphate buffer (pH 7.2), 0.15 M NaCl) in the 
ligand-free form (i.e., after charcoal or hexane treatment) 
and unfolded state (in the presence of 9.5 M urea). CD spec-
trum of a protein in 9.5 M urea is typical of random coils 
(completely unfolded state) while the CD spectra of the li-
gand-free form of AFP are very close to that of the native 
state, which excludes protein unfolding under these condi-
tions. As stripping the ligands does not affect considerably 
the shape and intensity of far-UV CD spectra of AFP (Fig. 
2), we can conclude that the protein has native-like content of 
secondary structure in the ligand-free form. 
3.3. Ligand-free form of AFP is compact 
To determine hydrodynamic dimensions of the AFP mole-
cule in different conformational states (native state, ligand-
free form and random coil with intact SS bonds) intrinsic 
viscosity [t|] values were measured. These values were used 
in calculations of the Stokes radius (Rs) values according to 
ref. [26] 
[n] = (2.5 NJM)(4/3KR3S) 
where 7Va is Avogadro's number and M is protein molecular 
weight. The corresponding [n] and Rs values are presented in 
Table 1. One can see that the presence of 9.5 M urea leads to 
considerable increase of AFP's hydrodynamic dimensions 
while the protein molecule in the ligand-free form is practi-
cally as compact as in the native state (see Table 1). 
3.4. Stripping the ligands from AFP is an irreversible process 
It is known that AFP possesses substantial heterogeneity 
connected mainly with different level of saturation with hy-
drophobic ligands (saturated and/or unsaturated fatty acids) 
[7] and/or different degree of glycosylation [7,12]. On the other 
hand, it was established that the composition of hydrophobic 
ligands bound to AFP depends considerably on the source of 
protein and method of its isolation and purification [7,12]. To 
avoid the effect of heterogeneity, a special rather harsh pro-
cedure of AFP isolation was elaborated [26]. As a result, 
homogeneous AFP samples were obtained. Gas chromatogra-
phy analysis allows to conclude that the major non-protein 
component of our AFP samples ( > 90%) is arachidonic acid 
(data not shown). 
SERUM 
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Fig. 3. Schematic representation of a two-receptor model for AFP endocytosis and FA transfer into target cell. rAFP, AFP receptors; rFA, 
FA receptors; AFP-FA, ligand-saturated form of AFP; rAFP-AFP, complex between rAFP and AFP; rFA-FA, complex between rFA and 
FA. Adapted from Ref. [32]. 
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It was revealed that stripping the FA ligands from human 
AFP by charcoal or hexane extraction is an irreversible proc-
ess. This means that native protein molecule cannot be recon-
stituted from the ligand-free form by adding back the major 
FA ligand of AFP — (in our samples) arachidonic acid. 
4. Discussion 
The results presented in this paper show that the release of 
ligands transforms molecules of human AFP into the molten 
globule state. Indeed, as it follows from near-UV CD and 
scanning microcalorimetric data (see Fig. 1 and Table 1) the 
ligand-free form of this protein has no rigid tertiary structure. 
On the other hand, at these conditions, the protein preserves 
native-like secondary structure (see Fig. 2 and Table 1). Fi-
nally, viscometry measurements clearly show (see Table 1) 
that the AFP molecule in the defatted (ligand-free) form is 
practically as compact as in the native state — its Rs exceeds 
the corresponding native value in ~1 .2 times, which is the 
usual case for molten globules [15,27-29]. Recently we have 
shown that decrease of pH also leads to transformation of 
native AFP molecules into the molten globule state [30]. 
We have also established that the release of AFP by char-
coal or hexane extraction is an irreversible process. This cor-
relates well with the earlier observation that "the delipidation 
of AFP by charcoal treatment at acid pH resulted in a loss of 
the subsequent FA-binding capacity of the protein" [31]. It is 
necessary to emphasize here that, from our point of view, the 
irreversibility of AFP delipidation is not connected with strip-
ping procedures used but determined mainly by the structural 
rearrangement of the protein molecule in ligand-free form. 
This suggestion is confirmed by our recent work [25] where 
we have established that any kind of AFP denaturation (in-
duced either by decrease of pH or increase of temperature or 
urea concentration) is an irreversible process connected with 
irreversible ligand release from the AFP molecule. 
It should be emphasized that such a structural transforma-
tion, induced by the release of ligands, can be associated with 
biological functioning of AFP. Indeed, one of the most im-
portant functions of AFP is the transport of various hydro-
phobic ligands [7-12]. A special two-receptor model for AFP 
endocytosis and FA transfer into a target cell was suggested 
[32]. This model was based on the results of microbiological 
investigations and proposed two different receptors on the cell 
surface-AFP- and FA-binding sites. Interaction of ligand-
saturated AFP molecules with the cell surface areas where 
AFP receptors are located leads to a conformational change 
in the protein accompanied by dissociation of the AFP-FA 
complex (see Fig. 3). The fatty acids are then translocated to 
nearby FA-binding sites on the cell surface. An FA-free AFP 
molecule can dissociate from an AFP receptor or can be 
transferred into the cell by endocytosis along with fatty acids 
(see Fig. 3). 
An intriguing possibility is that the ligand-free form of AFP 
studied in our paper might be considered as an in vitro coun-
terpart of the defatted AFP from the above model. As men-
tioned above, biological activities of AFP are rather diverse — 
from binding of various ligands [7-12] to regulation of im-
mune response [12-14]. We assume that structural transfor-
mations in the AFP molecule which occur after release of 
ligands might be important for the further functioning of 
this protein, for example, as immunoregulator. 
As for the driving forces of protein denaturation in a living 
cell, it is necessary to emphasize that membrane can cause 
partial unfolding of protein molecules [33] due to the negative 
charges on its surface and through decrease of the effective 
dielectric constant [19,34-36]. It has been established that the 
membrane-induced transition of a protein molecule into the 
molten globule state is of functional importance (see refs. [15] 
and [19] for recent reviews and references therein). This facil-
itates transmembrane protein transport [33] and toxin pene-
tration into membranes [37]. A similar mechanism was sug-
gested for membrane-mediated release of retinol from retinol-
binding protein [38] and we cannot exclude that an analogous 
mechanism may also apply to AFP. 
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